Skip to content

Molecular Diagnosis of Congenital Ichthyosis

GenDerm (GenoDermatoses) Project â?? Targeted Next Generation Sequencing in characterizing the genotypic variations Among Indian Patients with Congenital Ichthyosis and Assessing The Genotypic-Phenotypic Correlation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/024291
Enrollment
72
Registered
2020-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L86- Keratoderma in diseases classifiedelsewhere

Interventions

None listed

Sponsors

Indian Association of Dermatologists Venereologists and Leprologists
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: NONSYNDROMIC FORMS 1.COMMON ICHTHYOSES RXLI - Nonsyndromic presentation 2.AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSES: ARCI Major types Harlequin ichthyosis; HI Lamellar ichthyosis: LI Congenital ichthyosiform Erythroderma: CIE 3.KERATINOPATHIC ICHTHYOSES Major types Epidermolytic ichthyosis: EI Superficial epidermolytic ichthyosis: SEI 4.OTHER FORMS Loricrin Kertoderma SYNDROMIC ICHTHYOSIS 1.X-LINKED ICHTHYOSIS SYNDROMES RXLI syndromic presentation Ichthyosis follicularis atrichia photophobia Conradi-Hunermann-Happle syndrome 2.AUTOSOMAL ICHTHYOSIS SYNDROMES WITH PROMINENT HAIR ABNORMALITIES Netherton syndrome: NS Trichothiodystrophy: TTD PROMINENT NEUROLOGIC SIGNS Sjo¨gren-Larsson syndrome: SLS Refsum syndrome FATAL DISEASES COURSE CEDNIK syndrome ARC syndrome OTHER ASSOCIATED SIGNS KID syndrome Neutral lipid storage disease IPS

Exclusion criteria

Exclusion criteria: a. Ichthyosis vulgaris b. Patients with acquired ichthyosis c. Patients or parents not giving consent to undergo genetic testing

Design outcomes

Primary

MeasureTime frame
1. To study the mutation landscape in patients with congenital ichthyosis with next generation sequencing. 2. In silico analysis of mutations for pathogenic effect using bioinformatic tools. 3. Pattern of inheritance, phenotype genotype correlation with variants found in the candidate genes. 4. Designing a customized panel of genes for targeted resequencing for congenital ichthyosis in our patient population. Timepoint: 1.Recruitment of patients and clinical assessment of severity and morphologic subtype, collection of blood samples & isolation of DNA 1-15 months 2.Standardization of Sanger sequencing 6-12 months 3.Processing samples for NGS 1-24 months 4.Validation of results of NGS with Sanger sequencing 12-24 months 5.Statistical analysis 18-24 months

Secondary

MeasureTime frame
In silico analysis of mutations for pathogenic effect using bioinformatic tools. 3. Pattern of inheritance, phenotype genotype correlation with variants found in the candidate genes. 4. Designing a customized panel of genes for targeted resequencing for congenital ichthyosis in our patient population.Timepoint: 0-24 months

Countries

India

Contacts

Public ContactRahul Mahajan

Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India

drrahulpgi@yahoo.com7087009079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026